CartaBio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 4

CartaBio General Information

Description

Developer of diagnostic technology designed to decode cellular behavior to advance therapeutics. The company specializes in spatial omics imaging, single-cell analytics, AI-driven cell state modulation, and longitudinal biomarker tracking, enabling clients to reduce costs, accelerate discovery, and improve precision in immune-related drug development.

Contact Information

Website
www.cartabio.ai
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 87 Richmond Road
  • Belmont, MA 02478
  • United States
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Therapeutic Devices
Corporate Office
  • 87 Richmond Road
  • Belmont, MA 02478
  • United States

CartaBio Timeline

202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CartaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 10-Oct-2024 Completed Startup
2. Angel (individual) 25-Apr-2024 Completed Startup
1. Accelerator/Incubator 12-Oct-2023 Completed Startup
To view CartaBio’s complete valuation and funding history, request access »

CartaBio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Endless Frontier Labs Accelerator/Incubator
Coho Deeptech Venture Capital Minority
Danen Capital Venture Capital Minority
Harvard Innovation Launch Lab Accelerator/Incubator
To view CartaBio’s complete investors history, request access »

CartaBio FAQs

  • When was CartaBio founded?

    CartaBio was founded in 2023.

  • Where is CartaBio headquartered?

    CartaBio is headquartered in Belmont, MA.

  • What industry is CartaBio in?

    CartaBio’s primary industry is Biotechnology.

  • Is CartaBio a private or public company?

    CartaBio is a Private company.

  • What is CartaBio’s current revenue?

    The current revenue for CartaBio is .

  • How much funding has CartaBio raised over time?

    CartaBio has raised $1.38M.

  • Who are CartaBio’s investors?

    Endless Frontier Labs, Coho Deeptech, Danen Capital, and Harvard Innovation Launch Lab have invested in CartaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process